Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Friday, March 31, 2017

Updates on Clinical Trials NCT02683876 and NCT02692495

Irene Gabashvili, Director of MEBO Research
MEBO Metabolomic Profiling Study
Updates on Clinical Trials NCT02683876 and NCT02692495

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Anonymous said...

Thank you. Very interesting study and looking forward to the next phase. Exscuse my understanding but how do we find a cure once we discover all the compounds?

Apr 3, 2017, 6:35:00 PM
Irene Gabashvili said...

we need to define different sub-types of this condition as different treatment approaches will be needed.

Apr 8, 2017, 10:45:00 PM
Anonymous said...

Thank you Irene. Your reply has given me hope. We really appreciate all the work you do for us.

Apr 9, 2017, 8:42:00 AM
Ja za said...

Thank you Irene for all your work. It looks like you guys are the only ones that are looking into this issue. Two questions:

I understand amino acids can break down and cause these odorous compounds but do you have a theory on why the majority of suffers respond negatively to sugar? Somrthing like a fruit juice causes an instant reaction for me.

I see that the majority of participants were low in certain aminos, is this because a faulty pathway is not utilizing the amino acids properly and therefore being released as odorous compounds instead of being properly utilized by the body?

Apr 16, 2017, 3:18:00 PM
blogcontributor2 said...

I would suggest the best way to comment to Irene is via her youtube channel (Aurametrix)

Apr 18, 2017, 3:21:00 PM
Post a Comment